Matches in SemOpenAlex for { <https://semopenalex.org/work/W2003196989> ?p ?o ?g. }
- W2003196989 endingPage "58" @default.
- W2003196989 startingPage "48" @default.
- W2003196989 abstract "Endothelin and its receptors have long been considered therapeutic targets in the treatment of ischemic stroke. Recent studies indicate that ETB receptors may provide both vasodilatation and neuroprotection. The purpose of this study was to determine the effect of selectively activating the ETB receptors following permanent middle cerebral artery occlusion in rats. IRL-1620 [Suc-[Glu9,Ala11,15]-Endothelin-1(8-12)], a highly selective ETB agonist, was used alone and in conjunction with BQ788, an ETB antagonist, to determine the role of ETB receptors in cerebral ischemia. Rats were assessed for neurological deficit and motor function, and their brains were evaluated to determine infarct area, oxidative stress parameters, and ET receptor protein levels. Animals treated with IRL-1620 showed significant improvement in all neurological and motor function tests when compared with both vehicle-treated and BQ788-treated middle cerebral artery occluded groups. In addition, there was a significant decrease in infarct volume 24 h after occlusion in animals treated with IRL-1620 (24.47 ± 4.37 mm3) versus the vehicle-treated group (153.23 ± 32.18 mm3). Blockade of ETB receptors by BQ788 followed by either vehicle or IRL-1620 treatment resulted in infarct volumes similar to those of rats treated with vehicle alone (163.51 ± 25.41 and 139.21 ± 15.20 mm3, respectively). Lipid peroxidation, as measured by malondialdehyde, increased and antioxidants (superoxide dismutase and reduced glutathione) decreased following infarct. Treatment with IRL-1620 reversed these effects, indicating that ETB receptor activation reduces oxidative stress injury following ischemic stroke. Animals pretreated with BQ788 showed similar oxidative stress damage as those in the vehicle-treated group. No significant difference was observed in ETB receptor levels in any of the groups. The present study demonstrates that ETB receptor activation may be a novel neuroprotective therapy in the treatment of focal ischemic stroke." @default.
- W2003196989 created "2016-06-24" @default.
- W2003196989 creator A5039522776 @default.
- W2003196989 creator A5053781843 @default.
- W2003196989 creator A5062853798 @default.
- W2003196989 date "2011-10-01" @default.
- W2003196989 modified "2023-10-18" @default.
- W2003196989 title "Endothelin B receptor agonist, IRL-1620, reduces neurological damage following permanent middle cerebral artery occlusion in rats" @default.
- W2003196989 cites W1592448072 @default.
- W2003196989 cites W1775749144 @default.
- W2003196989 cites W1965077877 @default.
- W2003196989 cites W1970516435 @default.
- W2003196989 cites W1971424572 @default.
- W2003196989 cites W1983310681 @default.
- W2003196989 cites W1983845697 @default.
- W2003196989 cites W1985067219 @default.
- W2003196989 cites W1990738159 @default.
- W2003196989 cites W1994042168 @default.
- W2003196989 cites W1996660321 @default.
- W2003196989 cites W2000210641 @default.
- W2003196989 cites W2001470147 @default.
- W2003196989 cites W2006370393 @default.
- W2003196989 cites W2007213908 @default.
- W2003196989 cites W2007420041 @default.
- W2003196989 cites W2008737304 @default.
- W2003196989 cites W2011759289 @default.
- W2003196989 cites W2016597337 @default.
- W2003196989 cites W2022593257 @default.
- W2003196989 cites W2023434997 @default.
- W2003196989 cites W2030576462 @default.
- W2003196989 cites W2031203771 @default.
- W2003196989 cites W2032477901 @default.
- W2003196989 cites W2034290120 @default.
- W2003196989 cites W2038354943 @default.
- W2003196989 cites W2040448750 @default.
- W2003196989 cites W2042778005 @default.
- W2003196989 cites W2043876779 @default.
- W2003196989 cites W2045964357 @default.
- W2003196989 cites W2049110599 @default.
- W2003196989 cites W2049144486 @default.
- W2003196989 cites W2056706125 @default.
- W2003196989 cites W2059086113 @default.
- W2003196989 cites W2059315439 @default.
- W2003196989 cites W2084935848 @default.
- W2003196989 cites W2091647361 @default.
- W2003196989 cites W2105440614 @default.
- W2003196989 cites W2136452453 @default.
- W2003196989 cites W2140435475 @default.
- W2003196989 cites W2140936548 @default.
- W2003196989 cites W2147853442 @default.
- W2003196989 cites W2150253311 @default.
- W2003196989 cites W2170433626 @default.
- W2003196989 cites W4292172722 @default.
- W2003196989 cites W4297084930 @default.
- W2003196989 doi "https://doi.org/10.1016/j.brainres.2011.08.075" @default.
- W2003196989 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21959172" @default.
- W2003196989 hasPublicationYear "2011" @default.
- W2003196989 type Work @default.
- W2003196989 sameAs 2003196989 @default.
- W2003196989 citedByCount "41" @default.
- W2003196989 countsByYear W20031969892012 @default.
- W2003196989 countsByYear W20031969892013 @default.
- W2003196989 countsByYear W20031969892014 @default.
- W2003196989 countsByYear W20031969892015 @default.
- W2003196989 countsByYear W20031969892016 @default.
- W2003196989 countsByYear W20031969892018 @default.
- W2003196989 countsByYear W20031969892019 @default.
- W2003196989 countsByYear W20031969892020 @default.
- W2003196989 countsByYear W20031969892021 @default.
- W2003196989 countsByYear W20031969892022 @default.
- W2003196989 countsByYear W20031969892023 @default.
- W2003196989 crossrefType "journal-article" @default.
- W2003196989 hasAuthorship W2003196989A5039522776 @default.
- W2003196989 hasAuthorship W2003196989A5053781843 @default.
- W2003196989 hasAuthorship W2003196989A5062853798 @default.
- W2003196989 hasConcept C126322002 @default.
- W2003196989 hasConcept C134018914 @default.
- W2003196989 hasConcept C144980905 @default.
- W2003196989 hasConcept C149601957 @default.
- W2003196989 hasConcept C170493617 @default.
- W2003196989 hasConcept C25498285 @default.
- W2003196989 hasConcept C2775841333 @default.
- W2003196989 hasConcept C2776151105 @default.
- W2003196989 hasConcept C2778401633 @default.
- W2003196989 hasConcept C2778938600 @default.
- W2003196989 hasConcept C42219234 @default.
- W2003196989 hasConcept C541997718 @default.
- W2003196989 hasConcept C71924100 @default.
- W2003196989 hasConcept C98274493 @default.
- W2003196989 hasConceptScore W2003196989C126322002 @default.
- W2003196989 hasConceptScore W2003196989C134018914 @default.
- W2003196989 hasConceptScore W2003196989C144980905 @default.
- W2003196989 hasConceptScore W2003196989C149601957 @default.
- W2003196989 hasConceptScore W2003196989C170493617 @default.
- W2003196989 hasConceptScore W2003196989C25498285 @default.
- W2003196989 hasConceptScore W2003196989C2775841333 @default.
- W2003196989 hasConceptScore W2003196989C2776151105 @default.
- W2003196989 hasConceptScore W2003196989C2778401633 @default.